Patent disputes haven't materialized in the RNAi field yet, but once products near the market, it might be a different story. Charlie Schmidt investigates.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Angrist, M. & Cook-Deegan, R.M. The New Atlantis 11, 87–96 (2006).
Author information
Authors and Affiliations
Related links
Related links
Related links in Nature Research
Silent running: the race to the clinic
Safety concerns raised over RNA interference
RNA therapy tackles eye disease
Web links
Rights and permissions
About this article
Cite this article
Schmidt, C. Negotiating the RNAi patent thicket. Nat Biotechnol 25, 273–275 (2007). https://doi.org/10.1038/nbt0307-273
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0307-273